BB
Baudax Bio Inc develops and commercializes neuromuscular blocking agents (NMBAs) and a dedicated reversal agent for use in hospital and acute care settings. Their products aim to enhance patient safety and recovery by providing effective muscle relaxation during surgical procedures and enabling rapid reversal of neuromuscular blockade.
Updated 3 months ago
Funding
$72M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Baudax Bio Inc develops and commercializes neuromuscular blocking agents (NMBAs) and a dedicated reversal agent for use in hospital and acute care settings. Their products aim to enhance patient safety and recovery by providing effective muscle relaxation during surgical procedures and enabling rapid reversal of neuromuscular blockade.